Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-06

Clinical Trial Update: Gender-based Differences in the Outcome of the Treatment of Persistent Septic Shock With Hydrocortisone

View source ↗

Summary

A completed clinical trial from Alexandria University evaluates whether gender influences outcomes when treating persistent septic shock with hydrocortisone.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HYDROCORTISONE (HYDROCORTISONE)

Snippet

Sponsor: Alexandria University | Conditions: Septic Shock | Status: COMPLETED